37. James J. Kaminski, D. G. perkins, J. D. Frantz, Daniel M. Solomon, Arthur J. Elliott,P. J. S. Chiu, and James F. Long, J. Med. Chem. 1987, 30, 2047-2051.38. Alain Gueiffier, Mohammed Lhassani, Ahmed Elhakmaoui, Robert Snoeck, GracielaAndrei, Olivier Chavignon, Jean-Claude Teulade, Abdelali Kerbal, El MokhtarEssassi, Jean-Claude Debouzy, Myriam Witvrouw, Yves Blache, Jan Balzarini, ErikDe Clercq, And Jean-Pierre Chapat, J. Med. Chem. 1996, 39, 2856-2859.39. A. Gueiffier, Y. Blache, J. P. Chapat, A. Alhakmaoui, E. M. Essassi, G. Andrei, R.Snoeck, E. De Clercq, O. Chavignon, J. C. Teulade, F. Fauvelle, NucleosidesNucleotides 1995, 14(3-5), 551-554.40. A. Elhakmaoui, A. Gueiffier, J. C. Milhavet, Y. Blache, J. P. Chapat, O. Chavignon,J. C. Teulade, R. Snoeck, G. Andrei, E. De Clercq, BioOrg. Med. Chem. Lett. 1994,4(16), 1937-1940.41. C. Hamdouchi, J. Blas, M. Prado, J. Gruber, B. A. Heinz, L. vance, J. Med. Chem.1999,42, 50-59.42. W. S. Hamama, H. H. Zoorob, Tetrahedron 2002, 58, 6143-6162.43. R. J. Sundberg, S. Biswas, K. K. Murthi, D. Rowe, J. Med. Chem. 1998, 41, 4317-4328.44. Mohamed A. Ismail, Reto Brun, Tanja wenzler, Farial A. Tanious, W. David Wilson,and David W. Boykin, J. Med. Chem. 2004, 47, 3658-3664.45. R. R. Tidwell, D. W. Boykin, M. Demeunynck, C. Bailly, W. D. Wilson, Eds.; Wiley-VCH : New York, 2003; Vol. 2, pp 414-460.46. James J. Kaminski, D. G. Perkins, J. D. Frantz, Daniel M. Solomon, Arthur J. Elliott,P. J. S. Chiu, and James F. Long, J. Med. Chem. 1987, 30, 2047-2051.47. Kristjan S. Gudmundsson and Brian A. Johns, Org. lett. 2003, 5 (8), 1369-1372.48. A. Chaouni-Bendallah, C. Galtier, H. Allouchi, A. Kherbeche, O. Chavignon, J. C.Teulade, et al. ; Chem. Pharm. Bull. 2001, 49, 1631.49. S. V. Kostanecki and J. Tambor ; Chem. Ber., 1899, 32, 1921.50. K. Kazauki, K. Htayama, S. Yokomor and T. Soki ; Chem Abstr., 1976, 85, 5913.51. H. Rupe and D. Wasserzug; Chem Ber., 1901, 34, 3527.52. T. Szell ; Chem Ber., 1959, 92, 1672 ; Chem Abstr., 1959, 53, 21913.53. R. B. Lyle and L. P. Paradis ; J. American Chem. Soc., 1955, 77, 6667 ; ChemAbstr., 1956,50,10057.54. S. A. Hemes : Chem Abstr., 1969, 70, 96422h.164References…..
55. A. A. Rawal and N. M. Shah ; Indian J. Chem., 1962, 21, 234.56. P. L. Cheng, P. Fournari and J. Tirouflet ; Bull. Soc. Chim. France, 102248 (1963) ;Chem Abstr., 1964, 60, 1683.57. C. Kurodo and T. Matsukuma ; Sci. Papers Inst. Phys. Chem. Res. (Tokyo), 1932,18, 51 ; Chem. Abstr., 1932, 26, 2442.58. D. S. Breslow and C. R. Houser; J. American Chem. Soc., 1940 , 62, 2385 ; Chem.Abstr., 1940, 34, 7875.59. G. V. Jadav and V. G. Kulkarni ; Curr. Sci., 1944.60. L. Reichel ; Naturwissenschallen, 1944, 32, 215 ; Chem. Abstr., 1946, 10, 2441.61. V. M. Vlasov ; Chem. Abstr., 1972, 76, 40411d.62. P.L. Nayak and N. K. Rout ; J. Indian Chem. Soc., 1975, 52, 801.63. E. A. Mohamed, R. M. Abdel Rahman, A. A. Sayed and M. M. Ismail ; Indian J.Chem., Soc., 1992, 69, 82.64. K.P. Jadhav, D. B. Ingle ; Indian J. Chem., 1983, 22B, 180.65. P.S. Utale, P. B. Raghuvanshi, A. G. Doshi ; Asian J. Chem., 1998, 10(3), 597-599.66. S. W. Pfleiderer and H. Mosthafa ; Synthetic Org. Chem., B90, 1957,738.67. Rasaki Anatomic Osisany, James Olabisi Oluwadiya ; J. Heterocycl. Chem., 1989,26, 947.68. K. Folkers, S. A. Harris ; J. Am. Chem. Soc., 1939, 61, 1245.69. M. R. Mahmoud, Awatef E. F. E., M. S. Abd-El-Halim, A. M. Radwan ; Indian J.Heterocycl. Chem., 1994, 4, 131-136.70. A.Y. Deshmukh, P. B. Raghuwanshi, A. G. Doshi ; Oriental J. Chem., 2002, 18(1),101-104.71. M. A. El. Hashan, M. El-Kady, M. A. Saiyed, A. A. Elsawy ; Egypt. J. Chem., 1985,27(6), 715-21 (Eng) ; Chem. Abstr., 1986, 105, 208684.72. A. Sammour, Y. Akhnookh and H. Jahine ; U.A.R.J. Chem., 1970,13(4), 421-37 ;Chem. Abstr. 1972, 77, 101348q.73. L. S. Crawley and W. J. Fanshawe ; J. Heterocycl. Chem., 1977, 14, 53.74. A. Chan Seng H., Brimble Margaret ; Aus, J. Chem., 1998 ; Chem. Abstr., 1998,129, 16105f.75. A. Khalafallah ; Asian J. Chem., 1996, 8(4), 951-96.76. D. J. Brown ; Heterocycl. Compd., 16.77. E. C. Taylor and R. W. Morrison ; J. Org. Chem., 1967, 32, 2379.165References…..
- Page 3:
The Sarvodaya Education Society’s
- Page 6 and 7:
selfless help, moral support and gu
- Page 9 and 10:
Introduction and Spectral studies .
- Page 11 and 12:
“STUDIES ON SOME HETEROCYCLICENTI
- Page 13 and 14:
Pyrimidine derivatives have been pr
- Page 15 and 16:
Isoxazole derivative synthesized by
- Page 17 and 18:
“STUDIES ON SOMEHETEROCYCLIC ENTI
- Page 19 and 20:
(b) Pharmacokinetics: It is derived
- Page 21 and 22:
(C) Drug DevelopmentMany natural pr
- Page 23 and 24:
The process of drug design is exten
- Page 25 and 26:
(l) Non steroidal anti-inflammatory
- Page 27 and 28:
INTRODUCTIONThe aza-indolizine cont
- Page 29 and 30:
PHARMACEUTICAL IMPORTANTMuch resear
- Page 31 and 32:
Compd. R 1 R 2 R 3a :- H 7-Me-6,8-B
- Page 33 and 34:
S. Kristjan, Gudmundsson and A. Bra
- Page 35 and 36:
STUDIES ON IMIDAZOPYRIDINE DERIVATI
- Page 37 and 38:
(a) Chalcones with monoethanolamine
- Page 39 and 40:
Das B.P. et al. 111 have found that
- Page 41 and 42:
Furthermore, Alcaraz M.J, et al. 13
- Page 43 and 44:
REACTION SCHEMECl+ClOClOClClCH 3NH
- Page 45 and 46:
Instrument : SHIMADZU FTIR 8400 Spe
- Page 47 and 48:
SignalNo.SignalPosition(δppm)Relat
- Page 49 and 50:
ANTIMICROBIAL ACTIVITYProducts : Ch
- Page 51 and 52:
The reaction mixture was poured on
- Page 53 and 54:
TABLE NO.- 1A BIOLOGICAL SCREENING
- Page 55 and 56:
PART-IISTUDIES ON PYRIMIDINES
- Page 57 and 58:
The self consistent (pi)electron de
- Page 59 and 60:
class of dye viz. trichloro pyrimid
- Page 61 and 62:
ability to cleave nucleic acid targ
- Page 63 and 64:
SSNHNHoONOoONOo(11) (12)oOHThe Pyri
- Page 65 and 66:
called ABPP or bropirimine(2-amino-
- Page 67 and 68:
acid so that it could be utilized f
- Page 69 and 70:
have reported the 5-substitutedfuro
- Page 71 and 72:
maturation of the viral mRNA molecu
- Page 73 and 74:
Nevertheless, these compounds const
- Page 75 and 76:
OHHNCH 3Cl(CH 2 )nSNNR 2R 1N H 2NSR
- Page 77 and 78:
SECTION-ISTUDIES ONOXOPYRIMIDINES
- Page 79 and 80:
PHARMACEUTICAL IMPORTANCEIn recent
- Page 81 and 82:
REACTION SCHEMECH 3NNCHOCl10% KOH R
- Page 83 and 84:
INSTRUMENT :SHIMADZU FTIR 8400 Spec
- Page 85 and 86:
SignalNo.SignalPosition(δppm)Relat
- Page 87 and 88:
EXPERIMENTALSynthesis and therapeut
- Page 89 and 90:
TABLE NO.- 2(IB)PHYSICAL CONSTANTS
- Page 91 and 92:
INTRODUCTIONThiopyrimidine derivati
- Page 93 and 94:
H 3 COHNRH 3 CH 3 CNHS( IV ) R = ar
- Page 95 and 96:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 97 and 98:
IR SPECTRAL STUDIES OF 6-(2-(4-CHLO
- Page 99 and 100:
NMR SPECTRAL STUDIES OF 6-(2-(4-CHL
- Page 101 and 102:
MASS SPECTRAL STUDIES OF 6-(2-(4-CH
- Page 103 and 104:
[F] Antimicrobial activity of 6-(2-
- Page 105 and 106:
SECTION-IIISTUDIES ONAMINOPYRIMIDIN
- Page 107 and 108:
ArCHO+ArCOCH3NaOHMethanolR R 1ONaOH
- Page 109 and 110:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 111 and 112:
IR SPECTRAL STUDIES OF 4-(2-(4-CHLO
- Page 113 and 114:
NMR SPECTRAL STUDIES OF 4-(2-(4-CHL
- Page 115 and 116:
MASS SPECTRAL STUDIES OF 4-(2-(4-CH
- Page 117 and 118:
[F] Antimicrobial activity of 4-(2-
- Page 119 and 120:
PART-IIISTUDIES ONCYCLOHEXENONES
- Page 121 and 122:
2. Michael addition of chalcone wit
- Page 123 and 124:
Rheinheimer J. et al. 381have synth
- Page 125 and 126:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 127 and 128:
IR SPECTRAL STUDIES OF ETHYL-6-(2-(
- Page 129 and 130:
NMR SPECTRAL STUDIES OF ETHYL-6-(2-
- Page 131 and 132:
MASS SPECTRAL STUDIES OF ETHYL-6-(2
- Page 133 and 134:
Antimicrobial testing was carried o
- Page 135 and 136: PART-IVSTUDIES ON PYRAZOLINES
- Page 137 and 138: H 2 C= CHCN + Ar - NHNH 2NArN(3) 2
- Page 139 and 140: PHARMACEUTICAL IMPORTANCE :2- Pyraz
- Page 141 and 142: Kadu et al. 424 and antimicrobial b
- Page 143 and 144: REACTION SCHEMECH 3NNClCHO10% KOHRO
- Page 145 and 146: Instrument : SHIMADZU FTIR 8400 Spe
- Page 147 and 148: SignalNo.SignalPosition(δppm)Relat
- Page 149 and 150: EXPERIMENTALSynthesis and therapeut
- Page 151 and 152: TABLE NO.- 4(B)PHYSICAL CONSTANTS O
- Page 153 and 154: INTRODUCTION:Isoxazole come under t
- Page 155 and 156: PHARMACEUTICAL IMPORTANCE :Isoxazol
- Page 157 and 158: SYNTHESISAND THERAPEUTIC EVALUATION
- Page 159 and 160: IR SPECTRAL STUDIES OF 2-(4-CHLOROP
- Page 161 and 162: NMR SPECTRAL STUDIES OF 2-(4-CHLORO
- Page 163 and 164: MASS SPECTRAL STUDIES OF 2-(4-CHLOR
- Page 165 and 166: [F]Antimicrobial activity of 2-(4-c
- Page 167 and 168: PART-VISTUDIES ON OXIRANES
- Page 169 and 170: ( iii ) Epoxidation can also been c
- Page 171 and 172: Moreover, Nomura Yutaka et al. 487
- Page 173 and 174: SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 175 and 176: IR SPECTRAL STUDIES OF (3-(2-(4-CHL
- Page 177 and 178: NMR SPECTRAL STUDIES OF (3-(2-(4-CH
- Page 179 and 180: MASS SPECTRAL STUDIES OF (3-(2-(4-C
- Page 181 and 182: [F] Antimicrobial activity of (3-(2
- Page 184 and 185: 1. J. A. Joule and K. Mills; Hetero
- Page 188 and 189: 78. Ms. B. S. Hastak and B. J. Ghiy
- Page 190 and 191: 116. V. R. Mudalir and V. Joshi ; I
- Page 192 and 193: 150. S. Inoue, A. J. Saggimoto and
- Page 194 and 195: 197. S. S. Bahekar, D. B. Shinde; A
- Page 196 and 197: 238. A. Kreutzberger and M. Sellhei
- Page 198 and 199: 280. See, for example, W. H. Prusof
- Page 200 and 201: 326. C. W. Whitehead and J. J. Trav
- Page 202 and 203: 366. Nagarjan K., Shenoy S. J.; Ind
- Page 204 and 205: 396. Ausra Voskiene,Vytautas Mickev
- Page 206 and 207: 432. Solankee Sejal; Prajapati Yoge
- Page 208 and 209: 463. Mishra Ashutosh ; Jain Sanmati
- Page 210 and 211: 496. Kaneko Mashami, Saitoh Yutaka,
- Page 212 and 213: CH 3CH 3NNClNNClORHNONRRRC 6 H 5 -
- Page 214 and 215: CH 3CH 3NNClNNClEtOOCORHNNRRRC 6 H